| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.24 | 3e-09 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.28 | 8e-08 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.21 | 1e-07 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.18 | 1e-05 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.25 | 2e-05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.23 | 2e-05 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.19 | 3e-05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.27 | 4e-05 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.16 | 6e-05 |